Eilmeldung
Newsgather
BackWockhardt's Antibiotic Zaynich Gets US FDA Approval for Complicated UTIs
Wockhardt's Antibiotic Zaynich Gets US FDA Approval for Complicated UTIs
Gesundheit
Economic Times30.05.2026GesundheitIndia

Wockhardt's Antibiotic Zaynich Gets US FDA Approval for Complicated UTIs

Breakthrough Drug Targets Superbugs, Also Approved in India for UTIs and Bacteremia

Auf einen Blick

  • Wockhardt's novel antibiotic Zaynich (cefepime and zidebactam) has received US FDA approval for treating complicated urinary tract infections (UTIs), including pyelonephritis, caused by resistant microorganisms.
  • It also gained approval in India for UTIs and concurrent Gram-negative bacteremia, addressing the growing antimicrobial resistance threat.

KI-generierte Zusammenfassung

Schriftgröße

Wockhardt's novel antibiotic Zaynich (cefepime and zidebactam) has received US FDA approval for treating complicated urinary tract infections (UTIs), including pyelonephritis, caused by resistant microorganisms. It also gained approval in India for UTIs and concurrent Gram-negative bacteremia, addressing the growing antimicrobial resistance threat.

Read the full article on Economic Times

Verwandte Themen

This article was originally published by Economic Times.

Ähnliche Meldungen

Mehr zu diesem ThemaZaynich